# Anbio Biotechnology Class A Ordinary Shares (NNNN)

> Healthcare · DE · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NNNN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 12.06M | $ 8.69M | $ 0 | $ 0 | $ 30.16M |
| 2024 | $ 9.30M | $ 2.69M | $ 2.37M | $ 0 | $ 17.19M |
| 2023 | $ 7.85M | $ 2.63M | $ 1.05M | $ 0 | $ 14.82M |
| 2022 | N/A | N/A | N/A | $ 0 | $ 12.55M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.00 |
| Current Ratio | 344.31 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.00 |
| Gross Debt / FCF | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/NNNN.md)
- [Charts](https://sponda.capital/en/NNNN/charts.md)
- [Compare](https://sponda.capital/en/NNNN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.